KMA Remarketing Corporation – Trademark Portfolio
Entity Type: 03
KMA Remarketing Corporation holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 37 (Building & Construction) across 5 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include KMA BIOMEDICAL and KMA REMARKETING. The owner is based in DuBois, PA.
222 South Jared Street
DuBois, PA 15801
Showing of trademarks Trademarks
Trademark Classifications
KMA Remarketing Corporation's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does KMA Remarketing Corporation have?
KMA Remarketing Corporation has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does KMA Remarketing Corporation file in?
KMA Remarketing Corporation files trademarks across 5 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 37 (Building & Construction), Class 20 (Furniture), Class 36 (Insurance & Financial), Class 10 (Medical Apparatus). Class 35 covers advertising; business management; business administration; office functions.
What are KMA Remarketing Corporation's most well-known trademarks?
KMA Remarketing Corporation's registered trademark portfolio includes well-known marks such as KMA BIOMEDICAL and KMA REMARKETING. These are among 3 currently registered trademarks in the portfolio.
What is KMA Remarketing Corporation's trademark registration success rate?
KMA Remarketing Corporation has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.